Evaluating Nutritional Risk Factors for Delirium in Intensive-Care-Unit Patients: Present Insights and Prospects for Future Research.

bioelectrical impedance analysis delirium hypercatabolism intensive care medicine malnutrition

Journal

Clinics and practice
ISSN: 2039-7275
Titre abrégé: Clin Pract
Pays: Switzerland
ID NLM: 101563282

Informations de publication

Date de publication:
07 Dec 2023
Historique:
received: 08 10 2023
revised: 30 11 2023
accepted: 06 12 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 22 12 2023
Statut: epublish

Résumé

Malnutrition, hypercatabolism, and metabolic changes are well-established risk factors for delirium in critically ill patients. Although the exact mechanisms are not fully understood, there is mounting evidence suggesting that malnutrition can cause a variety of changes that contribute to delirium, such as electrolyte imbalances, immune dysfunction, and alterations in drug metabolism. Therefore, a comprehensive metabolic and malnutrition assessment, along with appropriate nutritional support, may help to prevent or ameliorate malnutrition, reduce hypercatabolism, and improve overall physiological function, ultimately lowering the risk of delirium. For this aim, bioelectrical impedance analysis can represent a valuable strategy. Further research into the underlying mechanisms and nutritional risk factors for delirium is crucial to developing more effective prevention strategies. Understanding these processes will allow clinicians to personalize treatment plans for individual patients, leading to improved outcomes and quality of life in the intensive-care-unit survivors.

Identifiants

pubmed: 38131687
pii: clinpract13060138
doi: 10.3390/clinpract13060138
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1577-1592

Auteurs

Arianna Piccirillo (A)

Otolaryngology and Maxillo-Facial Surgery Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, 80131 Naples, Italy.

Francesco Perri (F)

Medical and Experimental Head and Neck Oncology Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, 80131 Naples, Italy.

Alessandro Vittori (A)

Department of Anesthesia and Critical Care, ARCO ROMA, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy.

Franco Ionna (F)

Otolaryngology and Maxillo-Facial Surgery Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, 80131 Naples, Italy.

Francesco Sabbatino (F)

Medical Oncology Department, University of Salerno, 84084 Fisciano, Italy.

Alessandro Ottaiano (A)

SSD Innovative Therapies for Abdominal Metastases, Abdominal Oncology, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale", 80131 Naples, Italy.

Marco Cascella (M)

Unit of Anesthesiology, Intensive Care Medicine, and Pain Medicine, Department of Medicine, Surgery, and Dentistry, University of Salerno, Via Salvador Allende, 43, 84081 Baronissi, Italy.

Classifications MeSH